Literature DB >> 31271824

Fasting Reduces Intestinal Radiotoxicity, Enabling Dose-Escalated Radiation Therapy for Pancreatic Cancer.

Marimar de la Cruz Bonilla1, Kristina M Stemler1, Sabrina Jeter-Jones1, Tara N Fujimoto2, Jessica Molkentine2, Gabriela M Asencio Torres1, Xiaomei Zhang1, Russell R Broaddus3, Cullen M Taniguchi4, Helen Piwnica-Worms5.   

Abstract

PURPOSE: Chemotherapy combined with radiation therapy is the most commonly used approach for treating locally advanced pancreatic cancer. The use of curative doses of radiation in this disease setting is constrained because of the close proximity of the head of the pancreas to the duodenum. The purpose of this study was to determine whether fasting protects the duodenum from high-dose radiation, thereby enabling dose escalation for efficient killing of pancreatic tumor cells. METHODS AND MATERIALS: C57BL/6J mice were either fed or fasted for 24 hours and then exposed to total abdominal radiation at 11.5 Gy. Food intake, body weight, overall health, and survival were monitored. Small intestines were harvested at various time points after radiation, and villi length, crypt depth, and number of crypts per millimeter of intestine were determined. Immunohistochemistry was performed to assess apoptosis and double-strand DNA breaks, and microcolony assays were performed to determine intestinal stem cell regeneration capacity. A syngeneic KPC model of pancreatic cancer was used to determine the effects of fasting on the radiation responses of both pancreatic cancer and host intestinal tissues.
RESULTS: We demonstrated that a 24-hour fast in mice improved intestinal stem cell regeneration, as revealed by microcolony assay, and improved host survival of lethal doses of total abdominal irradiation compared with fed controls. Fasting also improved survival of mice with orthotopic pancreatic tumors subjected to lethal abdominal radiation compared with controls with free access to food. Furthermore, fasting did not affect tumor cell killing by radiation therapy and enhanced γ-H2AX staining after radiation therapy, suggesting an additional mild radiosensitizing effect.
CONCLUSIONS: These results establish proof of concept for fasting as a dose-escalation strategy, enabling ablative radiation in the treatment of unresectable pancreatic cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31271824      PMCID: PMC6754784          DOI: 10.1016/j.ijrobp.2019.06.2533

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  32 in total

1.  Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters.

Authors:  Paul W Tetteh; Onur Basak; Henner F Farin; Kay Wiebrands; Kai Kretzschmar; Harry Begthel; Maaike van den Born; Jeroen Korving; Frederic de Sauvage; Johan H van Es; Alexander van Oudenaarden; Hans Clevers
Journal:  Cell Stem Cell       Date:  2016-01-28       Impact factor: 24.633

2.  Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration.

Authors:  Ciara Metcalfe; Noelyn M Kljavin; Ryan Ybarra; Frederic J de Sauvage
Journal:  Cell Stem Cell       Date:  2013-12-12       Impact factor: 24.633

3.  Paneth Cell Multipotency Induced by Notch Activation following Injury.

Authors:  Shiyan Yu; Kevin Tong; Yanlin Zhao; Iyshwarya Balasubramanian; George S Yap; Ronaldo P Ferraris; Edward M Bonder; Michael P Verzi; Nan Gao
Journal:  Cell Stem Cell       Date:  2018-06-07       Impact factor: 24.633

4.  Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index.

Authors:  Changhan Lee; Fernando M Safdie; Lizzia Raffaghello; Min Wei; Federica Madia; Edoardo Parrella; David Hwang; Pinchas Cohen; Giovanna Bianchi; Valter D Longo
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

5.  Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.

Authors:  Daniel D Von Hoff; Ramesh K Ramanathan; Mitesh J Borad; Daniel A Laheru; Lon S Smith; Tina E Wood; Ronald L Korn; Neil Desai; Vuong Trieu; Jose L Iglesias; Hui Zhang; Patrick Soon-Shiong; Tao Shi; N V Rajeshkumar; Anirban Maitra; Manuel Hidalgo
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

6.  Calorie restriction (CR) reduces age-dependent decline of non-homologous end joining (NHEJ) activity in rat tissues.

Authors:  Jae-Eun Lee; Jee-In Heo; Seong-Hoon Park; Jeong-Hyeon Kim; Yoon-Jung Kho; Hong-Jun Kang; Hae Young Chung; Jong-Lull Yoon; Jae-Yong Lee
Journal:  Exp Gerontol       Date:  2011-07-29       Impact factor: 4.032

7.  Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity.

Authors:  Kelley S Yan; Olivier Gevaert; Grace X Y Zheng; Benedict Anchang; Christopher S Probert; Kathryn A Larkin; Paige S Davies; Zhuan-Fen Cheng; John S Kaddis; Arnold Han; Kelly Roelf; Ruben I Calderon; Esther Cynn; Xiaoyi Hu; Komal Mandleywala; Julie Wilhelmy; Sue M Grimes; David C Corney; Stéphane C Boutet; Jessica M Terry; Phillip Belgrader; Solongo B Ziraldo; Tarjei S Mikkelsen; Fengchao Wang; Richard J von Furstenberg; Nicholas R Smith; Parthasarathy Chandrakesan; Randal May; Mary Ann S Chrissy; Rajan Jain; Christine A Cartwright; Joyce C Niland; Young-Kwon Hong; Jill Carrington; David T Breault; Jonathan Epstein; Courtney W Houchen; John P Lynch; Martin G Martin; Sylvia K Plevritis; Christina Curtis; Hanlee P Ji; Linheng Li; Susan J Henning; Melissa H Wong; Calvin J Kuo
Journal:  Cell Stem Cell       Date:  2017-07-06       Impact factor: 24.633

8.  Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy.

Authors:  Changhan Lee; Lizzia Raffaghello; Sebastian Brandhorst; Fernando M Safdie; Giovanna Bianchi; Alejandro Martin-Montalvo; Vito Pistoia; Min Wei; Saewon Hwang; Annalisa Merlino; Laura Emionite; Rafael de Cabo; Valter D Longo
Journal:  Sci Transl Med       Date:  2012-02-08       Impact factor: 17.956

9.  Dll1+ secretory progenitor cells revert to stem cells upon crypt damage.

Authors:  Johan H van Es; Toshiro Sato; Marc van de Wetering; Anna Lyubimova; Annie Ng Yee Nee; Alex Gregorieff; Nobuo Sasaki; Laura Zeinstra; Maaike van den Born; Jeroen Korving; Anton C M Martens; Nick Barker; Alexander van Oudenaarden; Hans Clevers
Journal:  Nat Cell Biol       Date:  2012-09-23       Impact factor: 28.824

10.  The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study.

Authors:  Stefanie de Groot; Maaike P G Vreeswijk; Marij J P Welters; Gido Gravesteijn; Jan J W A Boei; Anouk Jochems; Daniel Houtsma; Hein Putter; Jacobus J M van der Hoeven; Johan W R Nortier; Hanno Pijl; Judith R Kroep
Journal:  BMC Cancer       Date:  2015-10-05       Impact factor: 4.430

View more
  9 in total

Review 1.  Fasting and fasting-mimicking diets for chemotherapy augmentation.

Authors:  Sebastian Brandhorst
Journal:  Geroscience       Date:  2021-01-07       Impact factor: 7.713

2.  Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma.

Authors:  Alexander Gähler; Denis I Trufa; Mircea T Chiriac; Patrick Tausche; Katja Hohenberger; Ann-Kathrin Brunst; Manfred Rauh; Carol I Geppert; Ralf J Rieker; Susanne Krammer; Anna Leberle; Markus F Neurath; Horia Sirbu; Arndt Hartmann; Susetta Finotto
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

Review 3.  The Molecular Link from Diet to Cancer Cell Metabolism.

Authors:  Shree Bose; Annamarie E Allen; Jason W Locasale
Journal:  Mol Cell       Date:  2020-06-05       Impact factor: 19.328

4.  Preclinical murine platform to evaluate therapeutic countermeasures against radiation-induced gastrointestinal syndrome.

Authors:  Paul B Romesser; Amanda S Kim; Jeho Jeong; Allison Mayle; Lukas E Dow; Scott W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-24       Impact factor: 12.779

Review 5.  The role and its mechanism of intermittent fasting in tumors: friend or foe?

Authors:  Xu Zhao; Jing Yang; Ruoyu Huang; Mengmeng Guo; Ya Zhou; Lin Xu
Journal:  Cancer Biol Med       Date:  2021-02-15       Impact factor: 4.248

Review 6.  Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma.

Authors:  Taiana Campos Leite; Rebecca Jean Watters; Kurt Richard Weiss; Giuseppe Intini
Journal:  J Transl Med       Date:  2021-10-29       Impact factor: 5.531

7.  Reprogramming of H3K9bhb at regulatory elements is a key feature of fasting in the small intestine.

Authors:  Christopher J Terranova; Kristina M Stemler; Praveen Barrodia; Sabrina L Jeter-Jones; Zhongqi Ge; Marimar de la Cruz Bonilla; Ayush Raman; Chia-Wei Cheng; Kendra L Allton; Emre Arslan; Ömer H Yilmaz; Michelle C Barton; Kunal Rai; Helen Piwnica-Worms
Journal:  Cell Rep       Date:  2021-11-23       Impact factor: 9.423

Review 8.  Nutritional Regulation of Mammary Tumor Microenvironment.

Authors:  Nikita Thakkar; Ye Bin Shin; Hoon-Ki Sung
Journal:  Front Cell Dev Biol       Date:  2022-02-02

Review 9.  Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.

Authors:  Marike W van Gisbergen; Emma Zwilling; Ludwig J Dubois
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.